Where does Andy Morley work?

Andy Morley is Principal at O2h Ventures.

Where did Andy Morley go to school?

Andy Morley studied at Nagoya University (Post Doc, Asymmetric Hydrogenation); The University of Salford (Ph D, Acyl-nitroso cycloadditions); Nagoya University.

Andy Morley

Investor

Principal at O2h Ventures

Congleton, England, United Kingdom

Find your path to Andy

233 people in our graph share verified history with Andy — schools, employers, funds. One of them is your warm intro.

Guillaume de ForcevilleunlockedAndy: together at Rhone-Poulenc Rorer (1993–1999)

×5Andy: together at Rhone-Poulenc Rorer

×6Andy: together at o2h group

About

Medicinal chemist with over 25 years of major pharma experience (Sanofi-Aventis, AstraZeneca) and author of over 55 publications and patents. He leads scientific evaluation of investments at o2h Ventures and serves as CSO of Opal Oncology.

Experience

o2h venturesChief Scientific Officercurrent2014 — present
o2h groupChief Scientific Officercurrent2014 — present
Opal Oncology LimitedCSOcurrent2012 — presentCambridge, United Kingdom
Andy Morley LTD3D Fragment Library Project Manager and Medicinal Chemistry Consultant2011 — 2013Cheshire
AstraZenecaPrincipal Scientist Medicinal Chemistry2007 — 2011
AstraZenecaTeam Leader, Medicinal Chemistry2000 — 2007
AventisSection Manager1999 — 2000
Rhone-Poulenc RorerSenior Research Fellow1998 — 1999
Rhone-Poulenc RorerSenior Research Scientist1992 — 1998

Skills & more

GPCRs24Kinases11Lead Optimisation6Competitive Intelligence2Lead Generation4Project Generation1Medicinal Chemistry64Drug Discovery75Lead Change18Organic Synthesis16ADME9Organic Chemistry23

+12 more

Pharmaceutical ResearchProject ManagementOutsourcingDrug DesignHeterocyclic ChemistryHPLCParallel SynthesisChemistryPharmaceutical IndustryInflammationDMPKLifesciences

Languages French · Japanese (elementary)

From Andy's professional profile.

Colleagues at O2h Ventures

Ajit Singh Guller

Marketing Manager at O2h Ventures

Catherine Beech

Independent Representative to the Investment Advisory Panel at O2h Ventures

Catherine Stace

VP - Strategic Relationships at O2h Ventures

Cengiz Tarhan

Independent Representative of the Investment Advisory Panel at O2h Ventures

Chris Reid

Venture Partner at O2h Ventures

Chris White

Vice President, Business Development at O2h Ventures

Dr Chris Torrance

Independent Representative of the Investment Advisory Panel at O2h Ventures

Gary Pitts

Compliance Consultant, Tetractys Limited at O2h Ventures

Frequently asked questions

Who is Andy Morley?: Medicinal chemist with over 25 years of major pharma experience (Sanofi-Aventis, AstraZeneca) and author of over 55 publications and patents. He leads scientific evaluation of investments at o2h Ventures and serves as CSO of Opal Oncology.
Where does Andy Morley work?: Andy Morley is Principal at O2h Ventures.
Where did Andy Morley go to school?: Andy Morley studied at Nagoya University (Post Doc, Asymmetric Hydrogenation); The University of Salford (Ph D, Acyl-nitroso cycloadditions); Nagoya University.

Same school

Also attended Nagoya University24

Praachi Jain MehtaChief of Staff at Augment Ventures Hyunwoong KimAssociate at Airbus Ventures Tomokatsu HongoDirector at Keio Innovation Initiative Takayuki HiranoAssociate Investment Director at Taiho Ventures, LLC Chen ZhuBoard Member Portfolio Companies at Aqua Spark Hanh DoEntrepreneurship Training Program (ETP) Coordinator at Memorial Centre for Entrepreneurship

+ 18 more

Also attended The University of Salford33

Edward LamDirector of Finance at The Spartan Group Essi HänninenOffice Manager at Innovestor Ventures Jim WilkinsonCFO at Oxford Science Enterprises Joe KellettInvestor at M33 Growth Edward Vaughan LuiPartner, Head of Impact at Bridges Fund Management Ltd.Ben HarrisonSenior Consultant at Resonance

+ 27 more

Shared employers

Also worked at o2h group7

Sunil ShahInvestor at O2h Ventures Nilesh DagiaVenture Partner at O2h Ventures Catherine StaceVP - Strategic Relationships at O2h Ventures Gayathri SadasivamVP - Scientific Due Diligence at O2h Ventures Riddhi AhujaSenior Fund Operations Manager at O2h Ventures Ajit Singh GullerMarketing Manager at O2h Ventures

+ 1 more

Also worked at AstraZeneca159

Detlev BiniszkiewiczManaging Director at MPM BioImpact Briggs MorrisonEntrepreneur Partner at MPM BioImpact Jung Lee, PhDVenture Partner at Adelphi Ventures Management, Llc Johan LundVenture Partner at Sciety Iliam BarkinoInvestor at Industrifonden Sara JawadInvestor at Industrifonden

+ 153 more

Also worked at Aventis247

Steve LiapisManaging Director at Northpond Ventures Walter OlesiakOperating Partner at Remiges Ventures, Inc.Christine AylwardFounder & Managing Partner at Magnetic Ventures Alan WaltsVenture Partner at Advent Life Sciences Sun AltbachSenior Scientific Advisor at BOLD Longevity Matt VineSenior Associate at RRE Ventures

+ 241 more

Also worked at Rhone-Poulenc Rorer7

Guillaume de ForcevillePartner at Pearl Advisory James ZanewiczPresident, Medicine & Research at Maykr Tina St. LegerChief Human Resources Officer at Immunocore JOANNA HOROBINExecutive Officer at Verastem Curtis QuigleyExecutive Officer at Celularity Marie-Laure OzouxFounder at Corteriapharma

+ 1 more